|
|
|||||||
| |||||||
| |||||||
| 1 | HOUSE RESOLUTION
| ||||||
| 2 | WHEREAS, Bisphenol A (BPA) is found in many consumer | ||||||
| 3 | products, such as baby bottles and other reusable containers | ||||||
| 4 | made from polycarbonate plastic and in the epoxy resin coating | ||||||
| 5 | used in most food and beverage cans, including canned infant | ||||||
| 6 | formula; and
| ||||||
| 7 | WHEREAS, Upon the request of the Commissioner of the United | ||||||
| 8 | State Food and Drug Administration (FDA), the FDA formed an | ||||||
| 9 | agency-wide BPA task force to facilitate cross-agency review | ||||||
| 10 | and evaluation of current research and new information on BPA | ||||||
| 11 | for all FDA regulated products and to make recommendations to | ||||||
| 12 | the Commissioner regarding actions the FDA should take next | ||||||
| 13 | regarding BPA; and
| ||||||
| 14 | WHEREAS, As part of its evaluation, the task force has | ||||||
| 15 | reviewed the concerns presented in the National Toxicology | ||||||
| 16 | Program Brief published in September 2008 by the National | ||||||
| 17 | Institutes of Health and the concerns presented in the Canadian | ||||||
| 18 | risk assessment released in October 2008; and
| ||||||
| 19 | WHEREAS, The FDA has considered the research and positions | ||||||
| 20 | of other transnational food safety organizations, including | ||||||
| 21 | the 2 risk assessments for BPA conducted by the European Food | ||||||
| 22 | Safety Authority's Scientific Panel on Food Additives, | ||||||
| |||||||
| |||||||
| 1 | Flavourings, Processing Aids and Materials in Contact with Food | ||||||
| 2 | and the Japanese National Institute of Advanced Industrial | ||||||
| 3 | Science and Technology; each of these documents considered the | ||||||
| 4 | question of a possible low-dose effect and concluded that no | ||||||
| 5 | current health risk exists for BPA at the current exposure | ||||||
| 6 | level; and
| ||||||
| 7 | WHEREAS, The FDA has been reviewing the emerging literature | ||||||
| 8 | on BPA on a continuous basis; and | ||||||
| 9 | WHEREAS, In August 2008, the FDA released a draft safety | ||||||
| 10 | assessment of BPA in food contact products and in October 2008, | ||||||
| 11 | the FDA Science Board provided recommendations to the FDA to | ||||||
| 12 | improve the safety assessment; and | ||||||
| 13 | WHEREAS, The FDA has reported back to the Science Board on | ||||||
| 14 | February 24, 2009 on the progress they have made to address the | ||||||
| 15 | Science Board recommendations; and
| ||||||
| 16 | WHEREAS, It is altogether fitting and proper and in the | ||||||
| 17 | public interest for us to urge the United States Food and Drug | ||||||
| 18 | Administration to expedite their current review of bisphenol A | ||||||
| 19 | in food containers and baby bottles; therefore, be it
| ||||||
| 20 | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE | ||||||
| 21 | NINETY-SIXTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that we | ||||||
| |||||||
| |||||||
| 1 | urge the United States Food and Drug Administration to expedite | ||||||
| 2 | its current review of the safety of bisphenol A in products | ||||||
| 3 | that contact food and take appropriate action based on its | ||||||
| 4 | findings; and be it further | ||||||
| 5 | RESOLVED, That a suitable copy of this resolution be | ||||||
| 6 | presented to the Commissioner of the United States Food and | ||||||
| 7 | Drug Administration and each member of the Illinois | ||||||
| 8 | congressional delegation.
| ||||||